Cornucopian Capital
Emerging managerBuilt from this firm's Form D filings. The firm files no SEC adviser report.
- HQ
- NJ
Cornucopian Capital uses long-term capital to build and support results-focused, high integrity companies. Its stated goal is helping people improve healthspan, enhance performance, and extend longevity, using scientific knowledge and accessible technologies.
01 · Says / Does
| Tag | Says | Does |
|---|---|---|
| Stages | Pre-seed, Seed, Series A, Series B | Not enough dated deals |
| Sectors | Consumer, Healthtech, Digital health, Biotech, Medical devices, Foodtech | Not enough dated deals |
| Regions | Not stated | Not enough dated deals |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| Cornucopian Capital I, L.P. Cornucopian Capital uses long-term capital to build and support results-focused, high integrity early-stage companies that use scientific knowledge and accessible technologies to help everyone attain improved healthspan, enhanced performance, and extended longevity. It invests from pre-Seed through Series B+ financings. Inferred from the firm's website | 2024 | $11.79M (Form D) | Open, writing first checks |
03 · People across funds
- Aryeh Ganz, Managing Director of the General Partner of the Issuer
Cornucopian Capital I, L.P. (Named on Form D)
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 28, 2026